Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1961 2
1962 3
1964 4
1965 1
1966 1
1967 1
1968 4
1969 1
1970 3
1971 3
1972 1
1973 1
1974 3
1975 1
1976 6
1977 2
1978 4
1979 2
1980 4
1981 6
1982 12
1983 18
1984 13
1985 23
1986 13
1987 10
1988 6
1989 14
1990 16
1991 8
1992 14
1993 10
1994 14
1995 16
1996 11
1997 6
1998 14
1999 20
2000 12
2001 33
2002 28
2003 31
2004 10
2005 12
2006 21
2007 9
2008 19
2009 18
2010 15
2011 21
2012 13
2013 13
2014 11
2015 21
2016 14
2017 12
2018 8
2019 18
2020 17
2021 15
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

640 results
Results by year
Filters applied: . Clear all
Page 1
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Yoshida K, et al. Among authors: kaji m. J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29. J Clin Oncol. 2019. PMID: 30925125 Free PMC article. Clinical Trial.
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, Katai H, Yoshikawa T, Ito S, Kaji M, Kimura Y, Hirao M, Yamada M, Kurita A, Takagi M, Lee SW, Takagane A, Yabusaki H, Hihara J, Boku N, Sano T, Sasako M. Iwasaki Y, et al. Among authors: kaji m. Gastric Cancer. 2021 Mar;24(2):492-502. doi: 10.1007/s10120-020-01136-7. Epub 2020 Nov 16. Gastric Cancer. 2021. PMID: 33200303 Clinical Trial.
[Myokymia].
Kaji M, Shoji H. Kaji M, et al. Nihon Rinsho. 1993 Nov;51(11):2866-70. Nihon Rinsho. 1993. PMID: 8277563 Review. Japanese.
[Coxsackie virus].
Kaji M. Kaji M. Nihon Rinsho. 2010 Jun;68 Suppl 6:418-21. Nihon Rinsho. 2010. PMID: 20942093 Japanese. No abstract available.
[Neuraminidase inhibitor].
Kaji M. Kaji M. Nihon Rinsho. 2000 Nov;58(11):2293-8. Nihon Rinsho. 2000. PMID: 11225320 Review. Japanese.
Lead and growth.
Kaji M, Nishi Y. Kaji M, et al. Clin Pediatr Endocrinol. 2006;15(4):123-8. doi: 10.1297/cpe.15.123. Epub 2006 Nov 3. Clin Pediatr Endocrinol. 2006. PMID: 24790332 Free PMC article. Review.
Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
Kurokawa Y, Doki Y, Mizusawa J, Terashima M, Katai H, Yoshikawa T, Kimura Y, Takiguchi S, Nishida Y, Fukushima N, Iwasaki Y, Kaji M, Hirao M, Katayama H, Sasako M. Kurokawa Y, et al. Among authors: kaji m. Lancet Gastroenterol Hepatol. 2018 Jul;3(7):460-468. doi: 10.1016/S2468-1253(18)30090-6. Epub 2018 Apr 28. Lancet Gastroenterol Hepatol. 2018. PMID: 29709558 Clinical Trial.
[Influenza].
Kaji M. Kaji M. Nihon Naika Gakkai Zasshi. 1990 Sep 10;79(9):1262-6. Nihon Naika Gakkai Zasshi. 1990. PMID: 2258671 Review. Japanese. No abstract available.
640 results